Market News

Bluebird Bio (BLUE) Market Value Rose While Advisory Research Has Cut Holding; Cintas (CTAS) Valuation Rose While Karp Capital Management Has Lowered Stake by $300,240

Karp Capital Management Corp decreased its stake in Cintas (CTAS) by 10.24% based on its latest 2017Q3 regulatory filing with the SEC. Karp Capital Management Corp sold 2,085 shares as the company’s stock rose 2.03% with the market. The institutional investor held 18,281 shares of the apparel company at the end of 2017Q3, valued at $2.64M, down from 20,366 at the end of the previous reported quarter. Karp Capital Management Corp who had been investing in Cintas for a number of months, seems to be less bullish one the $17.80B market cap company. The stock increased 0.11% or $0.18 during the last trading session, reaching $167.12. About 587,792 shares traded. Cintas Corporation (NASDAQ:CTAS) has risen 32.38% since February 19, 2017 and is uptrending. It has outperformed by 15.68% the S&P500.

Advisory Research Inc decreased its stake in Bluebird Bio Inc (BLUE) by 33.16% based on its latest 2017Q3 regulatory filing with the SEC. Advisory Research Inc sold 9,302 shares as the company’s stock rose 6.94% with the market. The hedge fund held 18,748 shares of the health care company at the end of 2017Q3, valued at $2.58M, down from 28,050 at the end of the previous reported quarter. Advisory Research Inc who had been investing in Bluebird Bio Inc for a number of months, seems to be less bullish one the $10.54 billion market cap company. The stock increased 2.25% or $4.7 during the last trading session, reaching $213.35. About 645,814 shares traded. bluebird bio, Inc. (NASDAQ:BLUE) has risen 112.34% since February 19, 2017 and is uptrending. It has outperformed by 95.64% the S&P500.

Advisory Research Inc, which manages about $11.47 billion and $6.28B US Long portfolio, upped its stake in Triangle Cap Corp Com (NYSE:TCAP) by 139,702 shares to 426,208 shares, valued at $6.09M in 2017Q3, according to the filing. It also increased its holding in Enlink Midstream Partners Lp (NYSE:ENLK) by 338,623 shares in the quarter, for a total of 8.99 million shares, and has risen its stake in Analogic (NASDAQ:ALOG).

Among 25 analysts covering bluebird bio (NASDAQ:BLUE), 14 have Buy rating, 2 Sell and 9 Hold. Therefore 56% are positive. bluebird bio had 81 analyst reports since August 11, 2015 according to SRatingsIntel. TH Capital initiated bluebird bio, Inc. (NASDAQ:BLUE) rating on Thursday, December 3. TH Capital has “Buy” rating and $121 target. The rating was maintained by Cantor Fitzgerald with “Sell” on Friday, June 23. On Monday, July 24 the stock rating was maintained by Cantor Fitzgerald with “Sell”. Oppenheimer initiated the shares of BLUE in report on Wednesday, December 20 with “Hold” rating. The stock of bluebird bio, Inc. (NASDAQ:BLUE) earned “Buy” rating by Canaccord Genuity on Thursday, February 1. The firm has “Neutral” rating given on Friday, June 30 by BTIG Research. The rating was downgraded by Morgan Stanley to “Underweight” on Monday, October 2. The firm earned “Buy” rating on Thursday, September 15 by Goldman Sachs. The firm has “Buy” rating by Jefferies given on Friday, October 23. Leerink Swann downgraded the stock to “Market Perform” rating in Thursday, January 25 report.

Analysts await bluebird bio, Inc. (NASDAQ:BLUE) to report earnings on February, 28. They expect $-1.63 EPS, up 13.30% or $0.25 from last year’s $-1.88 per share. After $-1.73 actual EPS reported by bluebird bio, Inc. for the previous quarter, Wall Street now forecasts -5.78% EPS growth.

Investors sentiment increased to 1.79 in 2017 Q3. Its up 0.11, from 1.68 in 2017Q2. It is positive, as 35 investors sold BLUE shares while 42 reduced holdings. 45 funds opened positions while 93 raised stakes. 49.05 million shares or 2.37% more from 47.91 million shares in 2017Q2 were reported. American Century has invested 0.03% in bluebird bio, Inc. (NASDAQ:BLUE). Legal & General Public Limited Liability Company stated it has 0% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE). Wellington Management Grp Ltd Liability Partnership reported 4.09 million shares. Natixis Asset Mgmt holds 9,429 shares or 0.11% of its portfolio. Susquehanna Group Llp reported 164,934 shares stake. Alliancebernstein Lp has 0.01% invested in bluebird bio, Inc. (NASDAQ:BLUE). National Bank Of America De, North Carolina-based fund reported 134,845 shares. Hightower Limited Liability Company reported 1,446 shares stake. 27,792 were accumulated by Westpac Corp. Utd Service Automobile Association holds 0.01% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE) for 29,810 shares. Macquarie Group Ltd holds 0% or 18,664 shares in its portfolio. Invesco Limited holds 191,906 shares. Teachers Retirement Systems Of The State Of Kentucky owns 29,081 shares. Atika Capital Mgmt Ltd owns 8,000 shares. California State Teachers Retirement holds 0.02% or 73,150 shares in its portfolio.

Karp Capital Management Corp, which manages about $168.02M and $215.19 million US Long portfolio, upped its stake in Alphabet by 354 shares to 3,863 shares, valued at $3.76 million in 2017Q3, according to the filing. It also increased its holding in I Shares Dow Jones U.S. R.E. I (IYR) by 3,944 shares in the quarter, for a total of 33,677 shares, and has risen its stake in Sector Spdr Tr Industrial (XLI).

Since January 12, 2018, it had 0 buys, and 1 sale for $1.99 million activity.

Among 15 analysts covering Cintas (NASDAQ:CTAS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Cintas had 42 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Wednesday, September 27 by Barclays Capital. The firm earned “Outperform” rating on Wednesday, August 17 by Robert W. Baird. RBC Capital Markets maintained Cintas Corporation (NASDAQ:CTAS) rating on Monday, July 17. RBC Capital Markets has “Hold” rating and $11800 target. Instinet downgraded the stock to “Neutral” rating in Tuesday, June 27 report. The stock of Cintas Corporation (NASDAQ:CTAS) earned “Buy” rating by Nomura on Friday, August 26. Stifel Nicolaus maintained the shares of CTAS in report on Tuesday, December 20 with “Hold” rating. Robert W. Baird maintained it with “Buy” rating and $185.0 target in Friday, December 22 report. The rating was maintained by Bank of America with “Underperform” on Friday, September 25. Morgan Stanley maintained the shares of CTAS in report on Wednesday, August 17 with “Underweight” rating. Barclays Capital maintained the stock with “Equal-Weight” rating in Tuesday, December 22 report.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.02, from 1.04 in 2017Q2. It dived, as 37 investors sold CTAS shares while 174 reduced holdings. 80 funds opened positions while 135 raised stakes. 69.32 million shares or 1.23% more from 68.47 million shares in 2017Q2 were reported. The Germany-based Dekabank Deutsche Girozentrale has invested 0.09% in Cintas Corporation (NASDAQ:CTAS). State Treasurer State Of Michigan reported 25,867 shares stake. First Republic Investment Management Inc holds 508,458 shares or 0.53% of its portfolio. Apg Asset Mngmt Nv invested in 0.03% or 146,614 shares. Pggm Invs owns 0.02% invested in Cintas Corporation (NASDAQ:CTAS) for 31,234 shares. Millennium Mngmt Limited Co has invested 0.06% in Cintas Corporation (NASDAQ:CTAS). Rowland And Investment Counsel Adv stated it has 0.28% of its portfolio in Cintas Corporation (NASDAQ:CTAS). Ls Investment Limited Company reported 0.2% in Cintas Corporation (NASDAQ:CTAS). Artemis Invest Mgmt Llp stated it has 1.43% of its portfolio in Cintas Corporation (NASDAQ:CTAS). Johnson Inc has invested 0% of its portfolio in Cintas Corporation (NASDAQ:CTAS). Louisiana State Employees Retirement reported 5,300 shares. Aristotle Capital Management Ltd Liability holds 0.02% or 18,382 shares in its portfolio. Legal And General Public Limited Co, a United Kingdom-based fund reported 507,536 shares. Eulav Asset Mngmt reported 10,900 shares. 38,491 are owned by Stevens Capital Management Ltd Partnership.

Leave a Reply

Your email address will not be published. Required fields are marked *